Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 25 04:00PM ET
4.88
Dollar change
+0.05
Percentage change
1.04
%
Index- P/E10.81 EPS (ttm)0.45 Insider Own28.05% Shs Outstand47.65M Perf Week-2.20%
Market Cap235.26M Forward P/E28.71 EPS next Y0.17 Insider Trans-0.82% Shs Float34.68M Perf Month-12.86%
Income21.59M PEG- EPS next Q-0.22 Inst Own54.89% Short Float9.59% Perf Quarter-1.41%
Sales235.64M P/S1.00 EPS this Y-42.22% Inst Trans-2.11% Short Ratio5.75 Perf Half Y117.86%
Book/sh1.12 P/B4.35 EPS next Y-34.62% ROA9.54% Short Interest3.33M Perf Year79.41%
Cash/sh1.99 P/C2.45 EPS next 5Y- ROE57.54% 52W Range2.13 - 7.73 Perf YTD12.70%
Dividend Est.- P/FCF8.76 EPS past 5Y- ROI17.12% 52W High-36.87% Beta1.31
Dividend TTM- Quick Ratio1.50 Sales past 5Y-0.59% Gross Margin73.40% 52W Low129.11% ATR (14)0.34
Dividend Ex-Date- Current Ratio1.57 EPS Y/Y TTM15796.55% Oper. Margin14.12% RSI (14)40.72 Volatility5.73% 5.86%
Employees185 Debt/Eq2.09 Sales Y/Y TTM3.34% Profit Margin9.16% Recom3.00 Target Price4.33
Option/ShortYes / Yes LT Debt/Eq1.36 EPS Q/Q308.66% Payout0.00% Rel Volume0.40 Prev Close4.83
Sales Surprise-1.84% EPS Surprise-13.33% Sales Q/Q9.90% EarningsMay 02 AMC Avg Volume578.88K Price4.88
SMA20-8.32% SMA50-13.06% SMA20017.36% Trades Volume231,234 Change1.04%
Date Action Analyst Rating Change Price Target Change
Sep-28-21Upgrade Citigroup Neutral → Buy $11
Jun-25-20Resumed BofA/Merrill Underperform $9
Oct-08-19Downgrade Goldman Neutral → Sell $24 → $8
May-10-19Downgrade Citigroup Buy → Neutral $24
May-10-19Downgrade Cantor Fitzgerald Overweight → Neutral $57 → $20
Jan-17-19Initiated Leerink Partners Mkt Perform $21
Jan-03-19Downgrade Guggenheim Buy → Neutral
Nov-19-18Upgrade Goldman Sell → Neutral
Nov-02-18Downgrade JP Morgan Neutral → Underweight
Nov-02-18Downgrade BofA/Merrill Buy → Underperform
Apr-25-24 10:02AM
Apr-18-24 04:15PM
Apr-11-24 06:00PM
Apr-03-24 05:30PM
Mar-22-24 09:25AM
08:30AM Loading…
Mar-20-24 08:30AM
Mar-02-24 08:29AM
Mar-01-24 09:55AM
09:40AM
09:39AM
Feb-29-24 04:41PM
04:40PM
04:05PM
Feb-27-24 06:30PM
11:51AM
04:10PM Loading…
Feb-22-24 04:10PM
Feb-15-24 04:10PM
Feb-13-24 08:30AM
Jan-31-24 12:58PM
Jan-11-24 04:07PM
Jan-06-24 11:02AM
Dec-11-23 08:30AM
Nov-20-23 11:47AM
Nov-06-23 05:15PM
Nov-03-23 12:16PM
09:34AM
09:31AM
Nov-02-23 07:42PM
04:47PM
04:05PM
04:14PM Loading…
Oct-19-23 04:14PM
Oct-14-23 12:30PM
Oct-04-23 05:30PM
Sep-22-23 07:57AM
Sep-21-23 04:10PM
Aug-31-23 04:07PM
Aug-08-23 08:30AM
Aug-04-23 12:36PM
09:23AM
Aug-03-23 05:17PM
04:05PM
Jul-20-23 04:15PM
Jun-13-23 09:30AM
Jun-06-23 05:03PM
Jun-04-23 09:00AM
May-28-23 10:06AM
May-22-23 11:07AM
May-05-23 05:15PM
12:45PM
09:44AM
May-04-23 05:32PM
04:04PM
Apr-20-23 04:15PM
Apr-17-23 06:49AM
Apr-11-23 05:15PM
Mar-14-23 08:30AM
Mar-06-23 09:48AM
Mar-03-23 05:15PM
02:20PM
06:22AM
Mar-02-23 04:05PM
Feb-28-23 04:15PM
Feb-19-23 02:05PM
Feb-16-23 04:31PM
Feb-07-23 05:30PM
Feb-01-23 08:30AM
Jan-25-23 06:19AM
Jan-12-23 04:15PM
Jan-11-23 05:30PM
Jan-09-23 08:55AM
Dec-20-22 08:31AM
Dec-15-22 03:39PM
Dec-07-22 06:03PM
Dec-05-22 05:30PM
Dec-01-22 08:36AM
Nov-28-22 09:55AM
Nov-22-22 09:15AM
08:50AM
Nov-21-22 05:25PM
Nov-17-22 09:40AM
Nov-14-22 10:10AM
09:50AM
Nov-11-22 10:20AM
Nov-09-22 10:43AM
06:02AM
Nov-07-22 01:02PM
Nov-04-22 12:29PM
12:20PM
12:18PM
11:18AM
Nov-03-22 06:45PM
04:05PM
Nov-02-22 05:30PM
Oct-27-22 04:05AM
Oct-20-22 04:15PM
Oct-12-22 09:31AM
Oct-04-22 05:30PM
Sep-21-22 11:35AM
10:15AM
Sep-20-22 04:05PM
Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. It focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. The company was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
AUERBACH ALAN HPresident and CEOJan 03 '24Sale4.4941,396185,6986,936,947Jan 05 06:56 PM
NOUGUES MAXIMO FChief Financial OfficerJan 03 '24Sale4.4915,68270,348128,666Jan 05 06:49 PM
Ludwig Jeffrey JeromeChief Commercial OfficerJan 03 '24Sale4.4912,95658,11999,970Jan 05 07:00 PM
HUNT DOUGLAS MSee RemarksJan 03 '24Sale4.498,35837,493103,319Jan 05 06:42 PM
Wong Alvin FChief Scientific OfficerJan 03 '24Sale4.497,73334,68998,214Jan 05 07:03 PM
Wong Alvin FChief Scientific OfficerDec 04 '23Sale3.762801,05397,934Jan 10 04:41 PM
MILLER MICHAEL PATRICKDirectorNov 07 '23Sale2.8325,00070,80243,358Nov 09 04:19 PM
AUERBACH ALAN HPresident and CEOJul 03 '23Sale3.3160,698200,9836,978,343Jul 06 07:03 PM
NOUGUES MAXIMO FChief Financial OfficerJul 03 '23Sale3.3114,68048,608144,348Jul 06 07:12 PM
Ludwig Jeffrey JeromeChief Commercial OfficerJul 03 '23Sale3.3112,10340,075112,926Jul 06 07:08 PM
HUNT DOUGLAS MSee RemarksJul 03 '23Sale3.317,80925,857111,677Jul 06 07:06 PM
Wong Alvin FChief Scientific OfficerJul 03 '23Sale3.316,93822,973105,947Jul 06 07:16 PM
Senderowicz AdrianDirectorJun 13 '23Sale3.4527,00093,2800Jun 15 09:03 PM
WILSON TROY EDWARDDirectorJun 13 '23Sale3.4527,00093,269350Jun 15 09:14 PM
MOYES JAY MDirectorJun 13 '23Sale3.4522,00075,97016,322Jun 15 09:10 PM
MILLER MICHAEL PATRICKDirectorJun 13 '23Sale3.4513,50046,63041,358Jun 15 08:28 PM
Dorval AllisonDirectorJun 13 '23Sale3.4510,00034,50017,000Jun 15 09:01 PM
Stuglik Brian MDirectorJun 13 '23Sale3.469,90034,25231,958Jun 15 09:06 PM
Wong Alvin FChief Scientific OfficerJun 02 '23Sale3.45269928112,885Jun 06 04:36 PM
Last Close
Apr 25 04:00PM ET
20.50
Dollar change
+0.01
Percentage change
0.05
%
SKM SK Telecom Co Ltd ADR daily Stock Chart
Index- P/E9.73 EPS (ttm)2.11 Insider Own0.01% Shs Outstand382.86M Perf Week2.09%
Market Cap7.70B Forward P/E9.88 EPS next Y2.07 Insider Trans0.00% Shs Float375.56M Perf Month-7.66%
Income824.66M PEG1.13 EPS next Q0.58 Inst Own5.94% Short Float0.20% Perf Quarter-0.39%
Sales13.48B P/S0.57 EPS this Y4.43% Inst Trans-10.00% Short Ratio2.74 Perf Half Y-0.87%
Book/sh22.29 P/B0.92 EPS next Y5.80% ROA3.43% Short Interest0.76M Perf Year4.01%
Cash/sh3.62 P/C5.67 EPS next 5Y8.60% ROE9.61% 52W Range18.52 - 22.71 Perf YTD-4.21%
Dividend Est.1.32 (6.45%) P/FCF5.20 EPS past 5Y-2.67% ROI5.30% 52W High-9.73% Beta0.84
Dividend TTM0.70 (3.40%) Quick Ratio0.92 Sales past 5Y-2.34% Gross Margin21.22% 52W Low10.69% ATR (14)0.27
Dividend Ex-DateSep 28, 2023 Current Ratio0.94 EPS Y/Y TTM18.79% Oper. Margin9.94% RSI (14)41.07 Volatility0.91% 1.16%
Employees5579 Debt/Eq1.01 Sales Y/Y TTM0.42% Profit Margin6.12% Recom1.43 Target Price24.48
Option/ShortYes / Yes LT Debt/Eq0.82 EPS Q/Q-14.02% Payout- Rel Volume0.82 Prev Close20.49
Sales Surprise0.56% EPS Surprise10.26% Sales Q/Q5.95% EarningsFeb 05 BMO Avg Volume275.70K Price20.50
SMA20-1.11% SMA50-4.59% SMA200-1.85% Trades Volume226,254 Change0.05%
Date Action Analyst Rating Change Price Target Change
Oct-31-19Upgrade JP Morgan Neutral → Overweight
May-21-19Initiated Macquarie Outperform
Dec-07-18Upgrade Nomura Neutral → Buy
Oct-30-18Downgrade CLSA Buy → Outperform
Oct-26-18Upgrade HSBC Securities Hold → Buy
Feb-23-18Downgrade Macquarie Outperform → Neutral
Jan-11-18Downgrade Morgan Stanley Overweight → Equal-Weight
Dec-01-17Upgrade Citigroup Neutral → Buy
Apr-24-17Downgrade Citigroup Buy → Neutral
Oct-25-16Downgrade Macquarie Outperform → Neutral
Today 07:47AM
Apr-18-24 10:18PM
08:16AM
Apr-11-24 08:00AM
Mar-31-24 10:07PM
04:09AM Loading…
Feb-28-24 04:09AM
Feb-27-24 07:17PM
Feb-26-24 08:30AM
08:00AM
07:09AM
Feb-08-24 08:42PM
Nov-22-23 07:54PM
Nov-16-23 04:35AM
Nov-13-23 10:42AM
Nov-09-23 11:23AM
12:27AM Loading…
Nov-08-23 12:27AM
Nov-07-23 08:50AM
Oct-30-23 07:52AM
Oct-22-23 01:00AM
Oct-18-23 05:32AM
Oct-17-23 11:00AM
08:57AM
Oct-13-23 01:51AM
Oct-02-23 09:03AM
Sep-25-23 09:00PM
Sep-19-23 08:50AM
Sep-18-23 08:48PM
Sep-17-23 10:37PM
Aug-23-23 05:18PM
Aug-18-23 09:45AM
10:51PM Loading…
Aug-13-23 10:51PM
10:43PM
Aug-09-23 12:11PM
Aug-08-23 05:07AM
Jul-27-23 02:11PM
05:00AM
Jun-29-23 08:07PM
09:11AM
06:00AM
Jun-26-23 10:00AM
Jun-08-23 09:00PM
10:00AM
May-18-23 06:15AM
May-10-23 09:53AM
Apr-27-23 07:40AM
Mar-15-23 07:46AM
Mar-07-23 05:00AM
Mar-06-23 09:40AM
09:24AM
Feb-27-23 04:00AM
Feb-26-23 07:33PM
Feb-18-23 06:00PM
Feb-16-23 09:40AM
Feb-09-23 12:09AM
Jan-31-23 09:40AM
Jan-25-23 07:07AM
Jan-24-23 09:40AM
Jan-23-23 07:09AM
07:07AM
Oct-27-22 12:00PM
Aug-10-22 01:14PM
Aug-07-22 12:45PM
Mar-10-22 05:30AM
Feb-14-22 06:28PM
Feb-08-22 10:38AM
Feb-06-22 06:00PM
Feb-02-22 05:38PM
01:38PM
09:38AM
Jan-19-22 09:38PM
Jan-08-22 07:00PM
Jan-06-22 08:11PM
Jan-01-22 07:00PM
Dec-12-21 04:00PM
Sep-07-21 09:15PM
09:00PM
Jul-01-21 12:00PM
Jun-16-21 11:48PM
12:00PM
Jun-12-21 01:00PM
May-25-21 12:00PM
May-11-21 05:30PM
May-07-21 08:51AM
Apr-21-21 06:39AM
Apr-11-21 06:20AM
Apr-01-21 07:42AM
Mar-16-21 04:43AM
04:35AM
Jan-22-21 11:05AM
Jan-06-21 08:04PM
Jan-05-21 10:35PM
Dec-09-20 10:25AM
Nov-29-20 09:46AM
Oct-21-20 03:49AM
Oct-15-20 09:55PM
06:51PM
Oct-07-20 05:39PM
Sep-22-20 04:17PM
Sep-07-20 06:28AM
Aug-23-20 11:02PM
SK Telecom Co., Ltd. engages in the provision of wireless telecommunication and internet services. Its products include mobile phones, wireless data, information communication, and others. The company was founded on March 29, 1984 and is headquartered in Seoul, South Korea.